For citations:
Kostritca N.S., Rabinovich R.M., Shakhnovich R.M., Yavelov I.S., Gulyan R.G., Rytova Yu.K., Tereschenko S.N., Erlikh A.D., Pevzner D.V. Use of glycoprotein IIb/IIIa inhibitors in myocardial infarction in the Russian Federation, according to the Russian Registry of Acute Myocardial Infarction REGION-IM. Rational Pharmacotherapy in Cardiology. 2024;20(3):322-330. (In Russ.) https://doi.org/10.20996/1819-6446-2024-3045. EDN: KEQWBW
Email this article 